Author Archive

Pugatch Consilium Releases New Study on Regulatory Standards for Approval of Generic Medicines

Posted by:

Today Pugatch Consilium releases Generic drugs appraisal and approval: departing from the ‘one-size-fits-all’ approach.

Generic medicines – follow-on versions of off-patent innovative medicines – are designed to be interchangeable to the innovative reference product. As more sophisticated and complex medicines are developed, securing the safe and effective use of their follow-on products becomes increasingly challenging.

This report zeroes in on the existing gaps and challenges within the ‘one-size-fits-all’ model of generic drugs approval vis-à-vis two particularly complex drugs: Narrow Therapeutic Index (NTI ...

Continue Reading →
0

New Pugatch Consilium report finds Colombia could see over 100 new clinical trials and up over $450 million in economic gains per year with policy reform

Posted by:

Today Pugatch Consilium releases Challenges and Opportunities – Developing the Biotechnology Sector in Colombia.

The purpose of this report is to, firstly, give a comparative overview of the biotechnology sector in Colombia and, secondly, provide an estimate of how an improvement to Colombia’s policy environment can result in higher biotechnology outputs including rates of biomedical FDI and clinical trials.

The report maps the current policy environment as it relates to biotechnology in Colombia and gives a detailed comparison on key major biotechnology ...

Continue Reading →
0

Pugatch Consilium releases new edition of Building the Bioeconomy – Shows how economies that are successful in building a high-tech biotechnology capacity put the right enabling policies in place

Posted by:

Commissioned by the Biotechnology Industry Organization and authored by Pugatch Consilium this series of reports seek to provide an overview of those national innovation strategies, policies and best practices that have been successful in creating an environment in which biotechnologies and biotechnological innovation can flourish.

 

This year Building the Bioeconomy has grown from thirteen economies to sixteen, adding Colombia, Israel and Japan. As in previous editions the sample of economies is geographically and economically diverse with a mix of high-income mature ...

Continue Reading →
0

Pugatch Consilium at the New Delhi conference on Expanding Healthcare Access in India

Posted by:

Last thursday January 14, 2016, Prof Meir Pugatch spoke at the groundbreaking conference entitled “Growing the Innovative Bio-pharmaceutical Industry and Expanding Healthcare Access in India” in New Delhi convened by the The U.S.-India Business Council (USIBC) in partnership with the Department of Industrial Policy and Promotion (DIPP) and the Investment and Technology Promotion Division (ITP) of the Ministry of External Affairs. During the session, Prof Pugatch presented the findings of one of Pugatch Consilium’s latest studies on India, highlighting how ...

Continue Reading →
0

PUGATCH CONSILIUM LAUNCHES NEW REPORT ON BUILDING THE BIOECONOMY

Posted by:

Today Pugatch Consilium launches Building the Bioeconomy 2015 the second edition study of the policies and best practices that pave the way for a creating an environment and ecosystem that enables biotech innovation. The 2015 edition focuses on 13 countries: Brazil, China, India, Korea, Malaysia, Mexico, Russia, Singapore, South Africa, Switzerland, Turkey, the UK and the United States. Using a comparative perspective and looking in detail at the country specific-level, the report identifies several important findings as well as lessons learned.

 

The report identifies ...

Continue Reading →
0

Pugatch Consilium releases new report on National Biotechnology Innovation strategies

Posted by:

Today Pugatch Consilium releases a new report on the development of national innovation strategies in the biotech sector commissioned by the Biotechnology Industry Organization (BIO).

The report, Building the Bioeconomy Examining National Biotechnology Industry Development Strategies, provides an overview of national innovation strategies, policies and best practices that relate to the building of a world-class biotechnology sector. It identifies key enabling policy input factors ranging from human capital, protection of intellectual property to infrastructure for research and development.

Through case ...

Continue Reading →
0

The US Chamber of Commerce and Pugatch Consilium’s Dr David Torstensson launch 2nd edition of the GIPC IP Index

Posted by:

Dr David Torstensson, Partner with Pugatch Consilium, is speaking at the international launch of the 2013 GIPC IP Index at the US Chamber of Commerce in Washington DC, USA. Pugatch Consilium has developed the GIPC IP Index in partnership with the US Chamber of Commerce’s Global Intellectual Property Center. The Index is a one-of-a-kind instrument that benchmarks and measures the national IP environment in 25 countries.

The launch of the 2013 Index will take place on January 29 2014 starting at ...

Continue Reading →
0

Pugatch Consilium at the World Creators Summit, June 4-5 2013 Washington DC

Posted by:

Dr David Torstensson, Senior Consultant with Pugatch Consilium, is attending the 2013 World Creators Summit in Washington DC, USA. Dr Torstensson is co-authoring a study of the creative economy in Brazil, Russia, India, China and South Africa commissioned by the International Confederation of Societies of Authors and Composers (CISAC) and is due for publication later this summer. He will be discussing the initial findings from this study at the World Creators Summit.

Dr Torstensson will be speaking on June 4th 2013 ...

Continue Reading →
0
Page 2 of 5 12345